Related Experiment Video
Updated: Sep 9, 2025

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Cryptococcus gattii meningitis in an immunocompromised patient in a hospital in the Peruvian Amazon: case report
Angel A Moreno-Soto1, Rodrigo J Cardenas-Golac1, Marco F Paredes-Obando1
1Universidad Nacional de la Amazonía Peruana, Iquitos, Perú.
Abstract:
We report a case of Cryptococcus gattii meningitis in a patient with HIV in the Peruvian Amazon. A 36-year-old male patient with severe neurological symptoms that was diagnosed by cerebrospinal fluid culture. Although liposomal amphotericin B and flucytosine are considered the standard antifungal therapy, due to a lack of resources, an alternative treatment of amphotericin B deoxycholate and fluconazole was used. Even with this alternative, treatment faced challenges due to the persistence of the microorganism. This case highlights the importance of considering C. gattii in the differential diagnosis of cryptococcal meningitis in immunocompromised patients, even in areas where the prevalence of this pathogen is low. The effectiveness of treatment and the patient's survival underscore the need for diagnostic and therapeutic strategies adapted to resource-limited settings.
Insights
Cryptococcus gattii meningitis occurred in an HIV patient in the Peruvian Amazon. An alternative treatment was used due to resource limitations, highlighting the need for adapted strategies in such settings.
Area of Science:
- Infectious Diseases
- Mycology
- Tropical Medicine
Background:
- Cryptococcal meningitis is a significant opportunistic infection in individuals with advanced HIV.
- Cryptococcus gattii is an emerging pathogen causing meningitis, particularly in immunocompromised hosts.
- Resource-limited settings present challenges in diagnosing and treating fungal infections like cryptococcosis.
Observation:
- A 36-year-old male with HIV presented with severe neurological symptoms.
- Cerebrospinal fluid culture confirmed Cryptococcus gattii meningitis.
- Standard antifungal therapy was unavailable; an alternative regimen of amphotericin B deoxycholate and fluconazole was administered.
Findings:
- The patient received an alternative antifungal regimen due to resource constraints.
- Treatment faced challenges, including persistent microorganism detection.
- Despite challenges, the patient survived, indicating potential effectiveness of adapted therapeutic strategies.
Implications:
- This case underscores the importance of considering Cryptococcus gattii in the differential diagnosis of cryptococcal meningitis in immunocompromised patients, irrespective of geographical prevalence.
- The successful management highlights the need for adaptable diagnostic and therapeutic approaches in resource-limited settings.
- Further research is warranted to optimize antifungal strategies for Cryptococcus gattii infections in underserved regions.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

